Blog
1 Massive Change in 2024 That Tesla Investors Must Know About
Part of the reason electric vehicles (EVs) have grown to be so popular in the U.S. is tax incentives. In the third quarter, EV sales topped 313,000, growing nearly 50% year over year. A big reason
Investing in Artificial Intelligence (AI) Stocks Can Be Risky, but Here's a Magnificent Way to Do It
The sun is setting on 2023, and just about every investor will agree that artificial intelligence (AI) was the theme of the year in the stock market.
It carried tech giants like Nvidia and Microsoft
Got $5,000? 3 Tech Stocks to Buy and Hold For the Long Term
Charlie Munger, Warren Buffett's longtime partner, passed away at age 99 last month. Perhaps Munger's biggest legacy? Spurring Buffett to switch from investing in very cheap stocks to investing in
Should You Buy Apple Stock in 2024?
Apple (NASDAQ: AAPL) is truly in a league of its own. It's the only company in the world with a market cap of over $3 trillion and has an exceptionally loyal customer base. Interbrand recently
3 Stocks to Buy for 2024 That Are Practically Money Machines
Follow the money. There's a lot of investing wisdom packed into those three words. Companies that generate huge profits and cash tend to have stocks that perform exceptionally well for investors
2 Warren Buffett Stocks to Buy Hand Over Fist and 1 to Avoid
Warren Buffett and Berkshire Hathaway (NYSE: BRK.A) (NYSE: BRK.B) own many stocks, but not all are great buys right now. However, Buffett has a few in his Berkshire portfolio with strong potential
2 Dividend Stocks That Will Pay You for Life
Investing in dividend stocks is a classic strategy for generating reliable passive income and mitigating the risk you take keeping your money in the equity markets.
This balance of passive income
Why I Plan to Pull Money Out of Stocks in 2024
I remain optimistic when it comes to the stock market's ability to build wealth over the long haul. Even with that perspective firmly in place, I plan to pull more money out of stocks in 2024 than I
Is SoFi Stock a Buy?
SoFi Technologies (NASDAQ: SOFI) has been on a wonderful run this year, up 111% as of Dec. 22. That's an impressive gain, especially given the higher interest rates we've seen in the United States.
5 Ultra-Popular Stocks I'd Sell Right Now
In just a matter of days, we'll wrap up what's been a banner year for Wall Street. The iconic Dow Jones Industrial Average recently reached a new all-time high. Meanwhile, the broad-based S&P 500
Starting a New Job in 2024? 3 Retirement Moves to Make Now
Most people see the beginning of a new year as a fresh start, including employers. January and February are some of the most popular hiring months, according to the job-search site Indeed, and that
3 Growth Stocks Expected to Skyrocket in 2024, According to Wall Street
In less than a week, Wall Street will turn the page on what's been a stellar year for optimists. The 30-component Dow Jones Industrial Average climbed to a record high, while the growth-driven
3 Social Security Changes Arriving in 2024
You'd think a program that's been around as long as Social Security wouldn't look so different from one year to the next. But you may be surprised at how many changes to the program arrive on a
1 Artificial intelligence (AI) Stock Down 80% to Buy Hand Over Fist for 2024
Fool.com contributor Parkev Tatevosian discusses why he thinks this artificial intelligence stock in particular is an excellent investment for 2024.
*Stock prices used were the afternoon prices of
1 Dividend Stock Down 53% You'll Regret Not Buying on the Dip
Fool.com contributor Parkev Tatevosian highlights why he considers this dividend stock one of the best for 2024.
*Stock prices used were the afternoon prices of Dec. 22, 2023. The video was
Best Dividend Stock 2024: Verizon Stock vs. AT&T Stock
Fool.com contributor Parkev Tatevosian discusses the importance of looking beyond the dividend yield when judging dividend stocks. Additionally, he determines which is the better dividend stock
Best EV Stocks 2024: Rivian Stock vs. Lucid Stock
Fool.com contributor Parkev Tatevosian compares Rivian (NASDAQ: RIVN) and Lucid (NASDAQ: LCID) to determine which is the better EV stock to buy for 2024.
*Stock prices used were the afternoon prices
1 Innovative Cathie Wood Growth Stock Down 74% to Buy Hand Over Fist for 2024
Fool.com contributor Parkev Tatevosian highlights one selection from Cathie Wood's portfolios that he believes makes an excellent investment for 2024 and beyond.
*Stock prices used were the
Best AI Stocks 2024: Tesla Stock vs. Nvidia Stock
Fool.com contributor Parkev Tatevosian compares Tesla (NASDAQ: TSLA) with Nvidia (NASDAQ: NVDA) to determine which is the better artificial intelligence (AI) stock to buy today to prepare your
Should Investors Buy the Dip in C3.ai Stock for 2024?
Fool.com contributor Parkev Tatevosian evaluates C3.ai (NYSE: AI) across several financial metrics, including valuation, to determine if investors should buy this artificial intelligence (AI) stock
Down 80%, Is XPENG Stock a Buy for 2024?
Fool.com contributor Parkev Tatevosian considers whether growth stock investors should buy XPENG (NYSE: XPEV) stock for 2024.
*Stock prices used were the afternoon prices of Dec. 21, 2023. The
Costco Stock Analysis: Buy, Sell, or Hold for 2024?
Fool.com contributor Parkev Tatevosian analyzes Costco's (NASDAQ: COST) business and why the company has been so successful.
*Stock prices used were the afternoon prices of Dec. 21, 2023. The video
Claiming Spousal Social Security Benefits? 3 Surprising Rules You Should Know.
Social Security is an essential piece of most Americans' retirement plans. Roughly half of individuals 65 or older live in households where 50% of family income comes from Social Security. So making
Is Palantir's Growth Too Dependent on Government Contracts?
Palantir Technologies (NYSE: PLTR), which is deeply involved with analytics and artificial intelligence (AI), has been growing both its commercial and government operations over the years.
However
Structure Therapeutics Stock Just Crashed. Here's Why It Could Be Worth Buying Now
Before biotech companies have sales to report to investors, their share prices often live and die on the enthusiasm they can build about their ongoing clinical trials. And when those trials


